Search In this Thesis
   Search In this Thesis  
العنوان
Synthesis of pyrazole derivatives as bioactive agents /
الناشر
Samar Ibrahim Mohamed Faggal ,
المؤلف
Samar Ibrahim Mohamed Faggal
هيئة الاعداد
باحث / Samar Ibrahim Mohamed Faggal
مشرف / Mohamed Abd-Elrahman Shaaban
مشرف / Aliaa Mohamed Kamal
مشرف / Khaled Omar Ahmed Mohamed
تاريخ النشر
2020
عدد الصفحات
153 P . :
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
صيدلة
تاريخ الإجازة
31/12/2020
مكان الإجازة
جامعة القاهرة - كلية الصيدلة - Organic Chemistry
الفهرس
Only 14 pages are availabe for public view

from 184

from 184

Abstract

This thesis includes four chapters. The first one is an introduction which is composed of three parts. The first part covering a brief literature survey on the synthesis of pyrazole and pyrazolo[5,1-b]quinazoline derivatives. The second part is a simple introduction covering the concept of inflammation, cyclooxygenase/ lipoxygenase enzymes. The third part deals with the classification of anti-inflammatory drugs based on their mode of action as well as anti-inflammatory activity of pyrazoles and quinazoline derivatives. The second chapter involves the objectives of the work, the scientific rationale of designing the new target compounds based on molecular hybridization and structural modification of both selective COX-2 inhibitors and dual COX-2/5-LOX inhibitors. It also demonstrates schemes (1-3) for the preparation of the new derivatives.Scheme 1 implicates the synthesis of 2-cyanoacetohydrazide (I) by reacting a mixture of ethyl cyanoacetae and hydrazine hydrate. The reaction of compound I with sodium ethoxide in precence of absolute ethanol yielded key precursor 3-amino-1H-pyrazol-5(4H)-one (II) which undergoes an unexpected cyclization with anthranilic acid to afford pyrazolo[5,1-b]quinazoline-2,9(1H,4H)-dione (III). The reaction of compound III with an equimolar amount of appropriate aromatic aldehyde in acetic acid buffered with sodium acetate yielded target 3-(substituted benzylidene)pyrazolo[5,1-b]quinazoline-2,9(1H,3H)-dione derivatives IVa-j. Scheme 2 is concerned with the preparation of the target compounds 4-substitutedbenzylidene-4,5-dihydro-5-oxo-1H-pyrazol-3-ylamino)benzoic acid VIa-h by condensation of 4-(4,5-dihydro-5-oxo-1H-pyrazol-3-ylamino)benzoic acid (V) and the appropriate aromatic aldehyde